Long-term Outcomes of Turbinate Surgery in Patients With Allergic Rhinitis: A Systematic Review and Meta-analysis
- PMID: 36394879
- PMCID: PMC9673023
- DOI: 10.1001/jamaoto.2022.3567
Long-term Outcomes of Turbinate Surgery in Patients With Allergic Rhinitis: A Systematic Review and Meta-analysis
Abstract
Importance: Turbinate surgery is an effective treatment for allergic rhinitis (AR) refractory to medical treatment. However, the long-term outcomes of turbinate surgery are still unclear and have not yet been confirmed by a meta-analysis and systematic review of the literature.
Objective: To investigate the long-term outcomes and safety of turbinate surgery in AR by performing a meta-analysis.
Data sources: MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov were searched through April 2021.
Study selection: Studies that analyzed turbinate surgery alone, had a follow-up period of more than 1 year, examined long-term efficacy of turbinate surgery, used current turbinate surgery methods, and were published in a peer-reviewed journal were included. Full-text reviews were performed by 2 independent reviewers. Conflicts were resolved by a third reviewer.
Data extraction and synthesis: Descriptive and quantitative data were extracted; weighted mean difference (WMD) was synthesized under a random-effects model. Heterogeneity was assessed using the Q statistic and the I2 metric. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines.
Main outcomes and measures: The long-term outcomes of turbinate surgery on subjective nasal symptoms and objective parameters.
Results: Of the 3962 citations retrieved, 18 studies comprising 1411 patients were included. Findings showed significantly decreased symptom scores in nasal obstruction (WMD, 4.60, 95% CI, 3.43-5.76), rhinorrhea (WMD, 3.12; 95% CI, 1.97-4.28), sneezing (WMD, 2.64; 95% CI, 1.74-3.54), itching (WMD, 1.75; 95% CI, 1.20-2.30), and nasal resistance (WMD, 0.16; 95% CI, 0.08-0.24) and a significant increased total nasal volume (WMD, 0.96; 95% CI, 0.73-1.19). There was no significant difference in the occurrence of any complication. More than 1 year after surgery, the improvements in nasal obstruction (WMD, 5.18; 95% CI, 3.00-7.37), rhinorrhea (WMD, 3.57; 95% CI, 1.78-5.37), and sneezing (WMD, 2.95; 95% CI, 1.58-4.32) were maintained.
Conclusions and relevance: In this systematic review and meta-analysis, turbinate surgery was associated with positive outcomes in AR and maintained the association during long-term follow-up. The rate of complications is also low. These findings can guide the preoperative counseling of patients with AR being considered for turbinate surgery.
Conflict of interest statement
Figures
Similar articles
-
Radiofrequency ablation of turbinates after septoplasty has no effect on allergic rhinitis symptoms other than nasal obstruction.Int Forum Allergy Rhinol. 2019 Nov;9(11):1257-1262. doi: 10.1002/alr.22420. Epub 2019 Aug 26. Int Forum Allergy Rhinol. 2019. PMID: 31449735 Clinical Trial.
-
Diode Laser Turbinate Reduction in Allergic Rhinitis: A Cross-sectional Study.JNMA J Nepal Med Assoc. 2018 Nov-Dec;56(214):949-952. doi: 10.31729/jnma.3870. JNMA J Nepal Med Assoc. 2018. PMID: 31065141 Free PMC article.
-
Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment.Cochrane Database Syst Rev. 2010 Dec 8;(12):CD005235. doi: 10.1002/14651858.CD005235.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154359 Review.
-
The submucosal approach influences long-term outcomes of refractory obstructive rhinitis: A prospective study and a STROBE analysis.Am J Otolaryngol. 2023 May-Jun;44(3):103808. doi: 10.1016/j.amjoto.2023.103808. Epub 2023 Mar 4. Am J Otolaryngol. 2023. PMID: 36905914 Clinical Trial.
-
[Leukotriene receptor antagonist as add-on therapy to intranasal corticosteroids in the treatment of allergic rhinitis: a systematic review].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Feb;29(3):207-11. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015. PMID: 26012288 Review. Chinese.
Cited by
-
Tissue specific stem cell therapy for airway regeneration.Cell Prolif. 2024 Oct;57(10):e13662. doi: 10.1111/cpr.13662. Epub 2024 May 27. Cell Prolif. 2024. PMID: 38803033 Free PMC article.
References
-
- Bousquet J, Schünemann HJ, Togias A, et al. ; Allergic Rhinitis and Its Impact on Asthma Working Group . Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. doi:10.1016/j.jaci.2019.06.049 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
